These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

40 related articles for article (PubMed ID: 119156)

  • 21. 'Superactivation' of alkaline phosphatase activity by cycloheximide in rat hepatoma cell cultures.
    Sorimachi K; Mizuno H; Yasumura Y
    J Pharm Pharmacol; 1984 Jul; 36(7):473-5. PubMed ID: 6146696
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential expression of the phenol family of UDP-glucuronosyltransferases in hepatoma cell lines.
    Kong AN; Fei P; Wong BK
    Pharm Res; 1995 Feb; 12(2):309-12. PubMed ID: 7784351
    [No Abstract]   [Full Text] [Related]  

  • 23. Precocious development of foetal glucuronidating enzymes induced by glucocorticoids in culture and in utero.
    Wishart GJ; Dutton GJ
    Nature; 1977 Mar; 266(5598):183-4. PubMed ID: 404564
    [No Abstract]   [Full Text] [Related]  

  • 24. Aryl hydrocarbon hydroxylase induction in mammalian liver-derived cell cultures. Effects of various metabolic inhibitors on the enzyme activity in hepatoma cells.
    Owens IS; Nebert DW
    Biochem Pharmacol; 1976 Apr; 25(7):805-13. PubMed ID: 181006
    [No Abstract]   [Full Text] [Related]  

  • 25. Enzyme induction in mammalian cells defective in 28S ribosomal RNA formation.
    Wiebel FJ; Bader JP; Gelboin HV
    Nature; 1976 Jan; 259(5541):331-3. PubMed ID: 1250370
    [No Abstract]   [Full Text] [Related]  

  • 26. Stimulatory effect of bleomycin on the hyaluronic acid synthetase in cultured fibroblasts.
    Otsuka K; Murota SI; Mori Y
    Biochem Pharmacol; 1978; 27(11):1551-4. PubMed ID: 81055
    [No Abstract]   [Full Text] [Related]  

  • 27. Variations in some molecular events during the early phases of the Reuber H35 hepatoma cell cycle. III. Role of protein synthesis in the initiation of DNA synthesis and the mechanism of stimulation of protein synthesis by serum.
    Streumer-Svobodova Z; Wiegant FA; van Dongen AA; van Wijk R
    Biochimie; 1982 Jun; 64(6):411-8. PubMed ID: 7115783
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Suppression of aryl hydrocarbon hydroxylase activity in human primary lung carcinoma x mouse hepatoma somatic cell hybrids.
    Manjunath GS; Dufresne MJ
    Biochem Int; 1989 Aug; 19(2):413-20. PubMed ID: 2818604
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ornithine decarboxylase induction in liver- and hepatoma-derived cell cultures: no detectable differences between control and 3-methylcholanthrene-treated cells.
    Kano I; Nebert DW
    Mol Pharmacol; 1981 Jul; 20(1):172-8. PubMed ID: 6270530
    [No Abstract]   [Full Text] [Related]  

  • 30. Persistently increased expression of a 3-methylcholanthrene-inducible phenol uridine diphosphate-glucuronosyltransferase in rat hepatocyte nodules and hepatocellular carcinomas.
    Bock KW; Münzel PA; Röhrdanz E; Schrenk D; Eriksson LC
    Cancer Res; 1990 Jun; 50(12):3569-73. PubMed ID: 2111208
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fate of inducer during induction of aryl hydrocarbon hydroxylase activity in mammalian cell culture. II. Levels of intracellular polycyclic hydrocarbon during enzyme induction and decay.
    Nebert DW; Bausserman LL
    Mol Pharmacol; 1970 Jul; 6(4):304-14. PubMed ID: 4193731
    [No Abstract]   [Full Text] [Related]  

  • 32. Enzyme induction (second of three parts).
    Gelehrter TD
    N Engl J Med; 1976 Mar; 294(11):589-95. PubMed ID: 54876
    [No Abstract]   [Full Text] [Related]  

  • 33. Induction of UDP-glucuronosyltransferase activity in the Reuber H-4-II-E hepatoma cell culture.
    Malik N; Koteen GM; Owens IS
    Mol Pharmacol; 1979 Nov; 16(3):950-60. PubMed ID: 119156
    [No Abstract]   [Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.